Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”

Nicolas Simon; Jean Alvarez

doi:10.1007/s00228-020-03056-y

Journal articles

Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”

Nicolas Simon ^{1, 2} Jean Alvarez ^{3, 4, 5, *}

* Corresponding author

1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale

2 Service de Pharmacologie Clinique [Hôpital de la Timone - APHM]

APHM - Assistance Publique - Hôpitaux de Marseille, TIMONE - Hôpital de la Timone [CHU - APHM]

3 2I - Infection et inflammation

4 MasSpecLab - Plateforme de spectrométrie de masse [Garches]

2I - Infection et inflammation

5 Hôpital Raymond Poincaré [AP-HP]

Abstract : No abstract available

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://www.hal.inserm.fr/inserm-03190820
Contributor : Christine Dupuis Connect in order to contact the contributor
Submitted on : Tuesday, April 6, 2021 - 4:19:34 PM
Last modification on : Wednesday, November 3, 2021 - 9:05:46 AM
Long-term archiving on: : Wednesday, July 7, 2021 - 6:48:58 PM

Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”

File

Restricted access

Identifiers

Collections

Citation

Export

Metrics

90

Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”

File

Restricted access

Identifiers

Collections

Citation

Export

Share

Metrics

90